
Mauvecobal Plus Injection
Marketer
Addsun Healthcare
Salt Composition
Folic Acid (0.7mg) + Methylcobalamin (1500mcg) + Niacinamide (12mg/ml)
Overview Mauvecobal Plus Injection
NutriBoost Injection, a multi-nutrient formulation, addresses nutritional deficits. It supports bodily growth and replenishes essential nutrients. Administered intravenously under medical guidance, self-injection is strictly prohibited. Dosage frequency is determined by the treating physician based on individual needs and symptom improvement. Continue treatment as directed. Generally well-tolerated with minimal adverse effects reported. Alcohol consumption is typically discouraged during treatment. Complete disclosure of all other medications is crucial, as interactions may compromise efficacy or alter the drug's action.
Uses of Mauvecobal Plus Injection
Inadequate nutrient intake
Major Benefits of Mauvecobal Plus Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mauvecobal Plus Injection:
- No common side effects seen
How to use Mauvecobal Plus Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Mauvecobal Plus Injection works:
A synergistic blend of Folic Acid, Methylcobalamin, and Niacinamide, Mauvecobal Plus Injection fortifies the body's essential nutrient reserves.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Mauvecobal Plus Injection and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Data on Mauvecobal Plus Injection use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can generally use Mauvecobal Plus Injection safely. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mauvecobal Plus Injection.
KidneySAFE IF PRESCRIBED
The use of Mauvecobal Plus Injection in patients with kidney disease appears to pose minimal risk. Available evidence indicates dose modification may not be necessary, but physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Mauvecobal Plus Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates that dosage modification may not be necessary for this patient population. However, physician consultation is recommended.
What if you forget to take Mauvecobal Plus Injection :
Omit a Mauvecobal Plus Injection dose? Seek your physician's advice.
Facts to Know About Mauvecobal Plus Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Essential Nutrients |
